Last Updated on October 15, 2024 by The Health Master
Hyderabad: Dr Reddy’s Laboratories, the Indian partner of the Russian Direct Investment Fund (RDIF), has not only sought approval from the Indian drug regulator, DCGI, for use of the single dose Russian vaccine, Sputnik Light, as a booster to the two-dose Sputnik V, but has also submitted a proposal for conducting trials of Sputnik Light as a booster to other vaccines.
The company is also working on bringing to India the two-dose vaccine for adolescents, Sputnik-M, that has been approved by the Russian regulator for use in children in the 12-18 age group.
“The same data has been made available to us here. We are in the process of reviewing and translating the data, and we will be having a conversation with DCGI within the next few months,” Deepak Sapra, CEO, API, Dr. Reddy’s Labs, said.
Pointing out that the company will have to conduct a clinical trial on the Indian population to use Sputnik-M on adolescents in India, he said that would depend on the guidance that the regulator will provide to the company.
Govt starts anti-dumping probe against Ursodiol, a chemical used in Pharma Industry
USFDA gives nod to Glenmark this for Blood Pressure drug
USFDA issues warning letter to Aurobindo Pharma for manufacturing lapses at API plant
Govt amends Drug Rules to include liquid antiseptic under Schedule K
Govt issues draft amendment in Rule 8 under New Drugs and Clinical Trials Rules 2019
USFDA gives Orphan Drug Designation to Eplontersen
India and Pharmacy Education: Chapter: 12
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
